These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 261515)

  • 1. Limited proteolysis of complement components C2 and factor B. Structural analogy and limited sequence homology.
    Kerr MA
    Biochem J; 1979 Dec; 183(3):615-22. PubMed ID: 261515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolysis of C2 and factor B: analyses of cleavage products by one- and two- dimensional peptide mapping.
    Ngan BY; Minta JO
    Mol Immunol; 1981 Dec; 18(12):1035-47. PubMed ID: 7038446
    [No Abstract]   [Full Text] [Related]  

  • 3. Human complement proteins D, C2, and B. Active site mapping with peptide thioester substrates.
    Kam CM; McRae BJ; Harper JW; Niemann MA; Volanakis JE; Powers JC
    J Biol Chem; 1987 Mar; 262(8):3444-51. PubMed ID: 3546307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The purification and properties of the second component of guinea-pig complement.
    Kerr MA; Gagnon J
    Biochem J; 1982 Jul; 205(1):59-67. PubMed ID: 6922702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The purification and properties of the second component of human complement.
    Kerr MA; Porter RR
    Biochem J; 1978 Apr; 171(1):99-107. PubMed ID: 417728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acid sequence of the Bb fragment from complement Factor B. Sequence of the major cyanogen bromide-cleavage peptide (CB-II) and completion of the sequence of the Bb fragment.
    Christie DL; Gagnon J
    Biochem J; 1983 Jan; 209(1):61-70. PubMed ID: 6342610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor D of the alternative pathway of human complement. Purification, alignment and N-terminal amino acid sequences of the major cyanogen bromide fragments, and localization of the serine residue at the active site.
    Johnson DM; Gagnon J; Reid KB
    Biochem J; 1980 Jun; 187(3):863-74. PubMed ID: 6821372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the CNBr peptides generated from the factor B cleavage fragments, Ba and Bb, by molecular exclusion high performance liquid chromatography.
    Niemann MA; Mole JE
    Immunol Commun; 1982; 11(1):47-58. PubMed ID: 6920359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural analysis of chicken factor B-like protease and comparison with mammalian complement proteins factor B and C2.
    Kjalke M; Welinder KG; Koch C
    J Immunol; 1993 Oct; 151(8):4147-52. PubMed ID: 8409391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reaction of iodine and thiol-blocking reagents with human complement components C2 and factor B. Purification and N-terminal amino acid sequence of a peptide from C2a containing a free thiol group.
    Parkes C; Gagnon J; Kerr MA
    Biochem J; 1983 Jul; 213(1):201-9. PubMed ID: 6555044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleavage of C2 by C1s into the antigenically distinct fragments C2a and C2b: demonstration of binding of C2b to C4b.
    Nagasawa S; Stroud RM
    Proc Natl Acad Sci U S A; 1977 Jul; 74(7):2998-3001. PubMed ID: 70787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage of the second component of complement by plasma proteases: implications in hereditary C1-inhibitor deficiency.
    Smith MA; Kerr MA
    Immunology; 1985 Nov; 56(3):561-70. PubMed ID: 2934317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid sequence of the Bb fragment from human complement Factor B. Alignment of the cyanogen bromide-cleavage peptides.
    Gagnon J; Christie DL
    Biochem J; 1983 Jan; 209(1):51-60. PubMed ID: 6342609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure of C2b, a fragment of complement component C2 produced during C3 convertase formation.
    Krishnan V; Xu Y; Macon K; Volanakis JE; Narayana SV
    Acta Crystallogr D Biol Crystallogr; 2009 Mar; 65(Pt 3):266-74. PubMed ID: 19237749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational changes during the assembly of factor B from its domains by (1)H NMR spectroscopy and molecular modelling: their relevance to the regulation of factor B activity.
    Hinshelwood J; Perkins SJ
    J Mol Biol; 2000 Sep; 301(5):1267-85. PubMed ID: 10966820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation, characterization and N-terminal sequences of the CNBr-cleavage peptides from human complement Factor B. Localization of a free thiol group and a sequence defining the site cleaved by factor D.
    Christie DL; Gagnon J
    Biochem J; 1982 Mar; 201(3):555-67. PubMed ID: 7092811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C2 and factor B: structure and genetics.
    Bentley DR; Campbell RD
    Biochem Soc Symp; 1986; 51():7-18. PubMed ID: 3101701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The principal site of glycation of human complement factor B.
    Niemann MA; Bhown AS; Miller EJ
    Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):473-80. PubMed ID: 2006911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human complement component C1s. Partial sequence determination of the heavy chain and identification of the peptide bond cleaved during activation.
    Spycher SE; Nick H; Rickli EE
    Eur J Biochem; 1986 Apr; 156(1):49-57. PubMed ID: 3007145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two forms of guinea pig factor B of the alternative complement pathway with different molecular weights.
    Matsushita M; Okada H
    Mol Immunol; 1989 Jul; 26(7):669-76. PubMed ID: 2779589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.